-
公开(公告)号:WO01072687A1
公开(公告)日:2001-10-04
申请号:PCT/IB2001/000428
申请日:2001-03-19
IPC: A61K31/137 , A61K31/145 , A61K31/165 , A61K31/18 , A61K31/195 , A61K31/24 , A61K31/277 , A61K31/397 , A61K31/40 , A61K31/415 , A61K31/4164 , A61K31/4192 , A61K31/4196 , A61K31/5375 , A61P15/00 , A61P15/10 , A61P25/00 , A61P25/14 , A61P25/24 , A61P25/30 , A61P43/00 , C07C45/71 , C07C47/55 , C07C47/575 , C07C205/44 , C07C213/02 , C07C213/08 , C07C217/58 , C07C217/90 , C07C229/38 , C07C237/28 , C07C237/30 , C07C255/43 , C07C255/59 , C07C303/38 , C07C311/05 , C07C311/08 , C07C311/37 , C07C317/32 , C07C319/20 , C07C323/20 , C07C323/32 , C07C323/67 , C07D205/04 , C07D207/12 , C07D231/38 , C07D233/61 , C07D249/06 , C07D249/08 , C07D295/08 , C07D295/096 , C07D295/18 , C07D295/192 , C07D521/00
CPC classification number: H04L12/14 , C07C45/71 , C07C47/55 , C07C47/575 , C07C205/44 , C07C217/58 , C07C229/38 , C07C237/28 , C07C255/43 , C07C255/59 , C07C311/05 , C07C311/08 , C07C311/37 , C07C317/32 , C07C323/20 , C07C323/32 , C07C323/67 , C07C2601/02 , C07C2601/08 , C07D231/12 , C07D231/38 , C07D233/56 , C07D249/06 , C07D249/08 , C07D295/096 , C07D295/192 , G06F11/2038 , G06F11/2097 , H04L12/1403
Abstract: A compound of general formula (I), or pharmaceutically acceptable salts, solvates or polymorphs thereof; wherein R is independ ently CF3, OCF3, C1-C4alkylthio or C1-C4alkoxy; n is 1, 2 or 3; and the other variables are as defined in the claims. These compounds inhibit monoamine re-uptake and in particular exhibit activity as selective serotonin re-uptake inhibitors. They are useful in disorders such as depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder, post-traumatic stress disorder, substance abuse disorders and sexual dysfunction including premature ejaculation.
Abstract translation: 通式(I)的化合物或其药学上可接受的盐,溶剂化物或多晶型物; 其中R 3独立地为CF 3,OCF 3,C 1 -C 4烷硫基或C 1 -C 4烷氧基; n为1,2或3; 并且其它变量如权利要求中所定义。 这些化合物抑制单胺再吸收,并且特别表现出作为选择性5-羟色胺再吸收抑制剂的活性。 它们可用于诸如抑郁症,注意缺陷多动障碍,强迫症,创伤后应激障碍,药物滥用障碍和包括早泄的性功能障碍在内的疾病。
-
公开(公告)号:WO1995032952A1
公开(公告)日:1995-12-07
申请号:PCT/EP1995001875
申请日:1995-05-17
Applicant: CIBA-GEIGY AG , KUNZ, Walter , SIEGRIST, Urs , BAUMEISTER, Peter
Inventor: CIBA-GEIGY AG
IPC: C07D239/54
CPC classification number: C07D239/54 , C07C235/28 , C07C237/28 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07D263/58 , C07D265/36 , C07D277/68 , C07D279/16 , C07D413/04 , C07D417/04
Abstract: Compounds of formula (I), wherein the substituents are as defined in claim 1 are prepared by: preparing a compound of formula (IV); converting that compound in the presence of an enaminating agent into the compound of formula (III); reacting that compound in the presence of a base and an inert solvent with a compound of formula (IIIa), wherein L1 and L2 are each independently of the other halogen, C1-C4 alkoxy, imidazol-1-yl or 1,2,4-triazol-1-yl, to form the compound of formula (II), and converting that compound in an inert solvent in the presence of a base with a compound of formula (IIa) R1-L3, wherein L3 is halogen or OSO2OR1, into the compound of formula (I). The compounds of formula (I) are suitable as herbicides.
Abstract translation: 式(I)化合物,其中取代基如权利要求1所定义,其通过:制备式(Ⅳ)化合物; 将该化合物在烯化剂的存在下转化为式(III)的化合物; 在碱和惰性溶剂的存在下,使该化合物与式(IIIa)化合物反应,其中L 1和L 2各自独立地为其它卤素,C 1 -C 4烷氧基,咪唑-1-基或1,2,4 - 三唑-1-基,形成式(II)化合物,并在惰性溶剂中,在碱的存在下,用式(IIa)的化合物R1-L3(其中L3为卤素或OSOO2OR1)转化该化合物, 转化为式(I)的化合物。 式(I)的化合物适合作为除草剂。
-
公开(公告)号:WO2013186153A2
公开(公告)日:2013-12-19
申请号:PCT/EP2013/061880
申请日:2013-06-10
Applicant: MEDIZINISCHE UNIVERSITÄT WIEN
Inventor: GSTACH, Hubert , CHIBA, Peter , MASTALIR, Matthias
IPC: C07D211/14 , C07D229/02 , C07C235/46 , C07C235/60 , C07D295/088 , A61K31/166 , A61K31/396 , A61K31/445
CPC classification number: C07D295/088 , C07C235/60 , C07C235/64 , C07C235/66 , C07C237/28 , C07C2601/02 , C07C2601/18 , C07C2601/20 , C07C2603/74 , C07D211/14 , C07D211/18 , C07D229/02
Abstract: The use of compounds of formula wherein R 2 , R 3 , R 4 , R 5 , R 6 and R 7 have several meanings, for the treatment of disorders mediated by protozoan organisms, novel compounds of the above formula and intermediates for the preparation of such compounds, pharmaceutical compositions comprising such novel compounds, a method of treating disorders mediated by protozoan organisms comprising administering such compounds, optionally together with a second drug substance, to a subject in need thereof and the use of such compounds, whenever comprising a photoaffinity label, for the identification of the molecular target(s) of arylamino alcohol antimalarials.
Abstract translation: 使用其中R 2,R 3,R 4,R 5,R 6和R 7具有几个含义的化合物用于治疗由原生动物生物介导的病症,上式的新化合物和用于制备这些化合物的中间体,药物组合物包含 这样的新化合物,一种治疗由原生动物生物介导的病症的方法,其包括向有需要的受试者施用任选与第二药物物质的这类化合物,以及每当包含光亲和标签时,使用这些化合物来鉴定 芳基氨基醇抗疟药的分子靶标。
-
公开(公告)号:WO2013186153A3
公开(公告)日:2014-02-27
申请号:PCT/EP2013061880
申请日:2013-06-10
Applicant: UNIV WIEN MED
Inventor: GSTACH HUBERT , CHIBA PETER , MASTALIR MATTHIAS
IPC: C07D211/14 , A61K31/166 , A61K31/396 , A61K31/445 , C07C235/46 , C07C235/60 , C07D229/02 , C07D295/088
CPC classification number: C07D295/088 , C07C235/60 , C07C235/64 , C07C235/66 , C07C237/28 , C07C2601/02 , C07C2601/18 , C07C2601/20 , C07C2603/74 , C07D211/14 , C07D211/18 , C07D229/02
Abstract: The use of compounds of formula wherein R2, R3, R4, R5, R6 and R7 have several meanings, for the treatment of disorders mediated by protozoan organisms, novel compounds of the above formula and intermediates for the preparation of such compounds, pharmaceutical compositions comprising such novel compounds, a method of treating disorders mediated by protozoan organisms comprising administering such compounds, optionally together with a second drug substance, to a subject in need thereof and the use of such compounds, whenever comprising a photoaffinity label, for the identification of the molecular target(s) of arylamino alcohol antimalarials.
Abstract translation: 使用其中R 2,R 3,R 4,R 5,R 6和R 7具有几个含义的化合物用于治疗由原生动物生物介导的病症,上式的新化合物和用于制备这些化合物的中间体,药物组合物包含 这样的新化合物,一种治疗由原生动物生物介导的病症的方法,其包括向有需要的受试者施用任选与第二药物物质的这类化合物,以及每当包含光亲和标签时,使用这些化合物来鉴定 芳基氨基醇抗疟药的分子靶标。
-
-
-